Intravitreal conbercept safe, effective against macular oedema secondary to CRVO
Intravitreal conbercept in three monthly loading doses, followed by a pro re nata regimen, is safe and effective for patients with macular oedema secondary to central retinal vein occlusion (CRVO), a recent China study has shown.
Intravitreal conbercept safe, effective against macular oedema secondary to CRVO
07 Aug 2020
